Call for Abstracts | CNSF Congress

JUNE 26 - 29, Sunday to WEDNESDAY | 2022 cnsf congress

Fairmont Hotel The Queen Elizabeth in Montreal, Quebec

The CNSF Congress continues to be the premier Canadian Congress for Neurologists, Neurosurgeons, Pediatric Neurologists, Neurophysiologists, Neuroradiologists and Neuroscientists. By submitting your work to our Congress, you gain the opportunity to disseminate your work across the entire spectrum of clinical neurosciences, as we are the only Congress to bridge the disciplines of our six member societies. We look forward to having you with us in Montreal!


NOTICE: 2021 Accepted Abstracts, submitted for the cancelled 2021 CNSF Congress, are published within the Canadian Journal of Neurological Sciences (CJNS) - November 2021 Abstract Supplement, available on Cambridge Core.

*2021 abstracts have not been carried forward to 2022.

Abstracts that have been previously published can be re-submitted to the CNSF Congress. This question is asked during the submission process and you must indicate “Yes”


In order to provide delegates with the most complete and accurate program, we must adhere to all deadlines noted below.  The onsite program and CJNS Abstract supplement are created based on final abstracts and Congress participants.

January 31, 2022

Abstract Submission Deadline - CLOSED

*After the close, you will be able to view or withdraw abstracts, and edit your contact details, but you will not be able to edit your abstracts.

January 31, 2022

Society Prize Submission Deadline - CLOSED

April 5, 2022 (Revised)

Acceptance notices sent

May 15, 2022

Presenting authors must be registered for the Congress by this date


The Abstract program will be finalized on this date (only registered authors will be included)

Abstract Submission Guidelines

Rules for Preparation of Abstracts

  • Authors are invited to submit an abstract, on or before January 31, 2022. No extensions to this date will be provided.
  • Each abstract should consist of four separate paragraphs. These should be labeled Background, Methods, Results, and Conclusions. Each abstract should, briefly and concisely, describe the problem or issue being addressed, how the study was performed, the salient results or findings, and what the authors conclude from these results.
  • Research presented in abstracts must conform to MRC guidelines for experimental procedures. All investigations involving humans and animals reported in CNSF publications must be conducted in conformity with these principles.
  • Abstracts are not to exceed 200 words, excluding title and authors. (tables count as 50 words)
  • Abstract titles are restricted to 140 characters.
  • Conflict of Interest: The CNSF requires presenting authors to declare any conflicts of interest by completing the online form within the abstract submission system.
  • Abstracts will be graded for quality. Primary authors are limited to 5 submissions and Contributing authors may be recognized on no more than 10 submissions.
  • International submissions are accepted however, authors must adhere to the same submission and registration deadlines as all others.  International delegates are expected to have their travel visa and any other documents required to leave their country and enter Canada, well in advance.  The CNSF does not issue letters of invitation.  Registration refunds are not granted due to inability to attend.  Any associated work will not be included in the program.

*CNSF members have the opportunity to win valuable society prizes by submitting an 'Abstract' to the Congress as well as an 'Expanded Abstract' to the society prize competitions. If you are also interested in submitting an 'Expanded Abstract' for a Society Prize learn more here: Call for Society Prizes | CNSF Congress

Instructions for Online Abstract Submissions

  • Please have full contact information for the submitting author and all potential presenting authors.
  • Spell out all unusual abbreviations in full.
  • When ready to submit, click on the online “Abstract submission site” link below.
  • Detailed instructions are available on the submission site as well as a full help menu and contact email for the Abstract Manager.
  • On completion of your submission, you will receive a confirmation by email. If you do not receive an email within 12 hours, please contact
  • Acceptance notices will be sent by e-mail at the end of April. If you have not received a notice by April 5, please check the status of your abstract by logging back into the abstract site and check your abstract details or contact
  • You must be registered for the 2022 Congress by May 15 or your abstract will be removed from the program.

All abstracts must be submitted online - No paper submissions will be accepted


Abstract Submission Site

How Abstracts are Judged and Assigned

Abstracts submitted by January 31st will be reviewed in February. Notification of acceptance and schedule information will be sent out by April 5, 2022. Abstracts will be judged on a scale of 1 to 4 according to certain criteria:

  1. Impact and relevance
  2. Scope, experience and research team
  3. Significance of findings and results
  4. Comprehensiveness and written quality of abstract.

Abstract reviewers are asked to make a global “accept” recommendation; although, final responsibility for abstract acceptance to the Congress will rest with the Scientific Program Committee.

Assigning Abstracts to Sessions

The Scientific Program Committee assigns papers to sessions on substantive grounds to make the scientific program as strong and attractive as possible. Most abstracts will be accepted for e-poster presentation. Society Prize winning abstracts will be presented during the Grand Plenary session, and the top papers will be offered a platform presentation during the “Chair’s Selects” session.

Digital Poster Presentation

Authors with abstracts selected for electronic posters, will have an opportunity to showcase their work to CNSF Congress delegates at multiple large screen viewing stations.

Presenting authors will also receive a scheduled time for stand-by poster presentation which allows for 4 minutes of oral presentation and 2 minutes allotted for questions, review and discussion. 

On-site digital posters will also be available in an online format for all Congress delegates.

SPC Chair’s Select Abstract Presentation

The Scientific Program Committee will select the top Abstracts submitted, to represent their Societies, during the Chair’s Select Presentations. 

Presenting authors will receive a scheduled time for their oral presentation, which allows for 6 minutes of oral presentation and 2 minutes allotted for questions, review and discussion. 

Author Registration for the 2022 Congress

All authors selected to present at the Congress must register for the Congress by May 15, 2022. Authors not registered by that date will have their presentations pulled from all Congress publications and onsite activities.

Abstract Subject Categories

Authors are asked to carefully select the Primary category and then the Secondary category to best describe your abstract submission.

Primary Category

(select one of the following)

Secondary Category

(select one of the following)

Adult Neurology (CNS / CSC)

Epilepsy and EEG

Neurosurgery (CNSS)

Neurovascular and Neurointerventional

Child Neurology (CACN)


Clinical Neurophysiology (CSCN)

Neurocritical Care

Neuroradiology (CSNR)



Neuroscience Education




Spine and Peripheral Nerve Surgery


Functional Neurosurgery and Pain




Neuromuscular Disease and EMG


Movement Disorders


Dementia and Cognitive Disorders


MS / Neuroinflammatory Disease


Metabolic Disease


Neurological Implications of Covid-19




Other Multidisciplinary


Other Adult Neurology


Other Child Neurology


Other Neurosurgery

 Abstract Review Criteria

4 – Exceptional

    • RCT: local, national or international
    • Clinical or basic science/lab or health systems research, in which a specific question has been asked, an investigation protocol has been developed, the study is powered adequately, statistical analyses are appropriate, the conclusions clearly stated, and there is potential for high impact.
    • A single patient or family study that establishes the presence of a hitherto un-described disease or kindred.
    • Unique historical research or educational study performed rigorously.

3 – Accept

    • Retrospective patient-based study that includes robust data/observations on an adequate # patients/subjects to allow a confident conclusion.
    • A single patient or family study, basic research study, or health systems study that adds new information to the field.
    • Less rigorous or unique historical, educational, basic science or health systems study.

2 – Borderline Accept

    • Retrospective patient-based study with just a handful of patients and that allows reasonable although essentially unsubstantiated conclusions to be drawn.
    • A single patient or family study, basic research study, or health systems study that adds NO new information to the field of neurosciences, but is considered useful or confirmatory information to bring to attendees.
    • Single patient case reports usually of rare or unusual conditions that essentially add nothing to the body of knowledge and are unlikely to be of much or any interest to attendees.
    • Case reports that denigrate the skills of other clinicians involved and/or that make a diagnosis entirely based on clinical opinion (“this is the diagnosis because I say it is....”).
    • Basic research or health systems research which adds NO new information to the field and is unlikely to be of much or any interest to attendees.
    • Minimal historic anecdotes.

1 – Not suitable for acceptance (Reject)

    • Not relevant to neurosciences
    • Incomprehensible language
    • Significant ethical concerns

Accepted abstracts will be published in the Canadian Journal of Neurological Sciences.